Skip to main content
Caplight Logo









Shionogi & Co.

Shionogi & Co.

Overview

Shionogi & Co., Ltd. is a Japanese pharmaceutical company that focuses on the research, development, manufacturing, and marketing of pharmaceutical products, particularly in the areas of infectious diseases, pain/central nervous system (CNS), and cancer. While its primary function is as an operating company, it also engages in strategic investments. In April 2025, the company established a Corporate Venture Capital (CVC) group to invest in seed, early, and mid-stage startups to identify future growth opportunities. The company also acts as a Limited Partner (LP) through investment agreements with venture capital funds like AN Venture Partners.

Portfolio Companies

13

Investments

Shionogi & Co. investments
CompanyDateStageLead
Celaid TherapeuticsOct 2026Series BCo-investor
Dioseve Inc.Jun 2026Series A ExtensionLead
Salubritas TherapeuticsDec 2025StrategicLead
CilcareDec 2024Series ACo-investor
AVITA, Inc.Aug 2024Series ACo-investor
Book a demo to see all 13 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Shionogi & Co. based?

Shionogi & Co. is headquartered in Japan.

When was Shionogi & Co. founded?

Founding year information for Shionogi & Co. is not publicly available.

How many portfolio companies does Shionogi & Co. have?

Shionogi & Co. has 13 portfolio companies in Caplight's dataset.

What are some companies in Shionogi & Co.'s portfolio?

Recent investments visible on Caplight include Celaid Therapeutics, Dioseve Inc., Salubritas Therapeutics, Cilcare, AVITA, Inc..

What was Shionogi & Co.'s most recent investment?

Shionogi & Co.'s most recent investment on Caplight was in Celaid Therapeutics in 2026.

What sectors does Shionogi & Co. focus on?

Shionogi & Co. focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does Shionogi & Co. focus on?

Shionogi & Co. typically invests at the Early stage.

Firmographic Details

HeadquartersJapan
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?